Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

Published Sep 28, 2019

NOW
PLAYING
Good News: Acupuncture May Offer Relief for Radiation Dry Mouth
NOW
PLAYING
This Gorgeous Mural Made by Children with Cancer is Completely Out of this World
NOW
PLAYING
NYC's Glitzy Madison Avenue Expected to Raise Over $100,000 for Childhood Cancer
NOW
PLAYING
NYC Debates Banning Paper Receipts with BPA, Which Some Say Could Be Linked to Cancer
NOW
PLAYING
New Evidence that Aspirin Reduces Mortality Risk for Certain Types of Cancer
NOW
PLAYING
Experts Tell SurvivorNet No Need to Panic about Hair Dye and Cancer Link